Cargando…
25 years of maturation: A systematic review of RNAi in the clinic
The year 2023 marks the 25th anniversary of the discovery of RNAi. RNAi-based therapeutics enable sequence-specific gene knockdown by eliminating target RNA molecules through complementary base-pairing. A systematic review of published and ongoing clinical trials was performed. Web of Science, PubMe...
Autores principales: | Corydon, Ida Juhl, Fabian-Jessing, Bjørn Kristensen, Jakobsen, Thomas Stax, Jørgensen, Asbjørn Cortnum, Jensen, Emilie Grarup, Askou, Anne Louise, Aagaard, Lars, Corydon, Thomas Juhl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424002/ https://www.ncbi.nlm.nih.gov/pubmed/37583575 http://dx.doi.org/10.1016/j.omtn.2023.07.018 |
Ejemplares similares
-
Animal Models of Choroidal Neovascularization: A Systematic Review
por: Fabian-Jessing, Bjørn K., et al.
Publicado: (2022) -
Associations between the Complement System and Choroidal Neovascularization in Wet Age-Related Macular Degeneration
por: Jensen, Emilie Grarup, et al.
Publicado: (2020) -
Toward lentiviral vectors for antiangiogenic ocular gene therapy
por: Askou, Anne Louise, et al.
Publicado: (2023) -
VEGFA-targeting miR-agshRNAs combine efficacy with specificity and safety for retinal gene therapy
por: Alsing, Sidsel, et al.
Publicado: (2022) -
Multigenic lentiviral vectors for combined and tissue-specific expression of miRNA- and protein-based antiangiogenic factors
por: Askou, Anne Louise, et al.
Publicado: (2015)